SMARCB1 involvement in the development of leiomyoma in a patient with schwannomatosis

American Journal of Surgical Pathology

Volumn 38, Issue 3, 2014, Pages 421-425

  Hulsebos, Theo J M ^a   Kenter, Susan ^a   Siebers Renelt, Ulrike ^e   Hans, Volkmar ^e   Wesseling, Pieter ^b,c   Flucke, Uta ^d  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^e EVANGELISCHES KRANKENHAUS   (Germany)

Author keywords

leiomyoma; predisposition; schwannomatosis; SMARCB1

Indexed keywords

DNA BINDING PROTEIN; NONHISTONE PROTEIN; SMARCB1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADULT; ARTICLE; CASE REPORT; CHEMISTRY; FEMALE; GENETIC PREDISPOSITION; GENETICS; HEREDITY; HETEROZYGOSITY LOSS; HUMAN; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; MUTATION; NEURILEMOMA; NEUROFIBROMATOSIS; NUCLEOTIDE SEQUENCE; PEDIGREE; PHENOTYPE; SCHWANNOMATOSIS; SKIN TUMOR; TUMOR SUPPRESSOR GENE; UTERINE CERVIX TUMOR;

ADULT; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; FEMALE; GENES, NEUROFIBROMATOSIS 2; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HEREDITY; HUMANS; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; LOSS OF HETEROZYGOSITY; NEURILEMMOMA; NEUROFIBROMATOSES; PEDIGREE; PHENOTYPE; SKIN NEOPLASMS; TRANSCRIPTION FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 84894443146     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000110     Document Type: Article

References (23)

1. Hulsebos TJ, Plomp AS, Wolterman RA, et al. Germline mutation of INI1/SMARCB1 in familial schwannomatosis. Am J Hum Genet. 2007;80:805-810
2. Plotkin SR, Blakeley JO, Evans DG, et al. Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria. Am J Med Genet A. 2013;161:405-416
3. Smith MJ, Walker JA, Shen Y, et al. Expression of SMARCB1 (INI1) mutations in familial schwannomatosis. Hum Mol Genet. 2012;21:5239-5245
4. Patil S, Perry A, Maccollin M, et al. Immunohistochemical analysis supports a role for INI1/SMARCB1 in hereditary forms of schwannomas, but not in solitary, sporadic schwannomas. Brain Pathol. 2008;18:517-519
5. Hadfield KD, Smith MJ, Urquhart JE, et al. Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas. Oncogene. 2010;29:6216-6221
6. Smith MJ, Kulkarni A, Rustad C, et al. Vestibular schwannomas occur in schwannomatosis and should not be considered an exclusion criterion for clinical diagnosis. Am J Med Genet A. 2012; 158A:215-219
7. Boyd C, Smith MJ, Kluwe L, et al. Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis. Clin Genet. 2008;74:358-366
8. Hadfield KD, Newman WG, Bowers NL, et al. Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis. J Med Genet. 2008;45:332-339
9. Bacci C, Sestini R, Provenzano A, et al. Schwannomatosis associated with multiple meningiomas due to a familial SMARCB1 mutation. Neurogenetics. 2010;11:73-80
10. Rousseau G, Noguchi T, Bourdon V, et al. SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosis. BMC Neurol. 2011;11:9
11. Melean G, Velasco A, Hernández-Imaz E, et al. RNA-based analysis of two SMARCB1 mutations associated with familial schwannomatosis with meningiomas. Neurogenetics. 2012;13:267-274
12. Christiaans I, Kenter SB, Brink HC, et al. Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple meningiomas. J Med Genet. 2011;48:93-97
13. Van den Munckhof P, Christiaans I, Kenter SB, et al. Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri. Neurogenetics. 2012;13:1-7
14. Versteege I, Sévenet N, Lange J, et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature. 1998;394: 203-206
15. Hollmann TJ, Hornick JL. INI1-deficient tumors: Diagnostic features and molecular genetics. Am J Surg Pathol. 2011;35:e47-e63
16. Forest F, David A, Arrufat S, et al. Conventional chondrosarcoma in a survivor of rhabdoid tumor: Enlarging the spectrum of tumors associated with SMARCB1 germline mutations. Am J Surg Pathol. 2012;36:1892-1896
17. Swensen JJ, Keyser J, Coffin CM, et al. Familial occurrence of schwannomas and malignant rhabdoid tumour associated with a duplication in SMARCB1. J Med Genet. 2009;46:68-72
18. Carter JM, O'Hara C, Dundas G, et al. Epithelioid malignant peripheral nerve sheath tumor arising in a schwannoma, in a patient with "neuroblastoma-like" schwannomatosis and a novel germline SMARCB1 mutation. Am J Surg Pathol. 2012;36:154-160
19. Ammerlaan AC, Ararou A, Houben MP, et al. Long-Term survival and transmission of INI1-mutation via nonpenetrant males in a family with rhabdoid tumour predisposition syndrome. Br J Cancer. 2008;98:474-479
20. Hasselblatt M, Oyen F, Gesk S, et al. Cribriform neuroepithelial tumor (CRINET): A nonrhabdoid ventricular tumor with INI1 loss and relatively favorable prognosis. J Neuropathol Exp Neurol. 2009; 68:1249-1255
21. Tomlinson IP, Alam NA, Rowan AJ, et al. Multiple Leiomyoma Consortium. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet. 2002;30:406-410
22. Dane B, Dane C, Basaran S, et al. Vaginal schwannoma in a case with uterine myoma. Ann Diagn Pathol. 2010;14:137-139
23. Gorlin RJ, Koutlas IG. Multiple schwannomas, multiple nevi, and multiple vaginal leiomyomas: A new dominant syndrome. Am J Med Genet. 1998;78:76-81